Helicobacter pylori and acid peptic disorders of the esophagus: Is it conceivable?

American Journal of Gastroenterology

Volumn 92, Issue 7, 1997, Pages 1097-1102

  Vicari, Joseph ^a   Falk, Gary W ^a   Richter, Joel E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN RELEASING PEPTIDE;

BACTERIAL VIRULENCE; BARRETT ESOPHAGUS; DISEASE ASSOCIATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL CARCINOMA; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; PATHOPHYSIOLOGY; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL DISEASES; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; GASTRIC ACID; GASTRIC EMPTYING; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; PEPTIC ULCER; STOMACH NEOPLASMS;

EID: 0030738068     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Kahrilas PJ, Hogan WJ. Gastroesophageal reflux disease. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease. Philadelphia: WB Saunders, 1993:378-90.
2. Collen MJ, Lewis JH, Benjamin SB. Gastric acid secretion in refractory gastroesophageal reflux disease. Gastroenterology 1990;98:654-61.
3. Fink SM, Barwick KW, DeLuca V, et al. The association of histologic gastritis with gastroesophageal reflux and delayed gastric emptying. J Clin Gastroenterol 1984;6:301-9.
4. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994;106:1174-83.
5. O'Connor HE, Canan K. Helicobacter pylori and gastro-esophageal reflux disease: A prospective study. Ir J Med Sci 1994;163:369-73.
6. Borkent MR, Beker A. Treatment of ulcerative reflux esophagitis with colloidal bismuth subcitrate in combination with cimetidine. Gut 1988; 29:385-9.
7. Francoual S, Lamy PH, Quintrec YL, et al. Helicobacter pylori: Has it a part in the lesion of gastroesophageal reflux? J Infect Dis 1990;162: 1414 (letter).
8. Cheng EH, Bermanski P, Silversmith M, et al. Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease. Arch Intern Med 1989;149:1373-5.
9. Walker SJ, Birch PJ, Stoddard CJ, et al. Patterns of colonisation of Campylobacter pylori in the esophagus, stomach, and duodenum Gut 1989;30:1334-8.
10. Kuipers EJ, Lundell L, Klinkenberg-Knol E, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334: 1018-22.
11. Dooley CP, Cohen H, Fitzgibbons PL, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989;321:1562-6.
12. Perez-Perez GI, Dworkin BM, Chodos JE, et al. Campylobacler pylori antibodies in humans. Ann Intern Med 1988;109:11-7.
13. Paull G, Yardley JH. Gastric and esophageal Campylobacter pylori in patients with Barrett's esophagus. Gastroenterology 1988;95:216-8.
14. Talley NJ, Cameron AJ, Shorter RG, et al. Campylobacter pylori and Barrett's esophagus. Mayo Clin Proc 1988;63:1176-80.
15. Loffeld RJ, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus. Am J Gastroenterol 1992;87:1598-600.
16. Gruppo Operativo Per Lo Studio Delle Precancerosi Esofagee (GOSPE). Helicobacter pylori in Barrett's esophagus. Histopathology 1991;18:568-70.
17. Ectors N, Geboes K, Janssens J, et al. Helicobacter pylori and the oesophagus. In: Pajares JM, Pena AS, Malfertheiner P, eds. H. pylori and gastroduodenal pathology. Berlin: Springer-Verlag, 1993:142-50.
18. Blaser MJ, Perez-Perez GI, Lindenbaum J, et al. Association of infection due to Helicobacter pylori with specific upper gastrointestinal pathology. Rev Infect Dis 1993;13(suppl 8):S704-8.
19. Quddus MR, Sulaiman RA, Henley JD, et al. Lack of association of Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus. Mod Pathol 1996;9:1 (abstract).
20. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265: 1287-9.
21. Hansson LE, Sparen P, Nyren O. Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg 1993;80: 374-7.
22. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
23. Cameron AJ, Lomboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-6.
24. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325: 1127-31.
25. Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol 1994;25:915-9.
26. Hansson LE, Engstrand L, Nyren O, et al. Helicobacter pylori infection: Independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993;105:1098-03.
27. Hansson LE, Engstrand L, Nyren O, et al. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995; 109:885-8.
28. Lin J, Wang J, Wang TH, et al. Helicobacter pylori infection in early and advanced gastric adenocarcinoma: A seroprevalence study in 143 Taiwanese patients. Hepatogastroenterology 1993;40:596-9.
29. El-Omar EM, Penman ID, Aortal JE, et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995;109:681-91.
30. Tee W, Lambert JR, Dryer B. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995;33:1203-5.
31. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology 1996; 110:926-38.
32. Pounder RE. Helicobacter pylori and gastroduodenal secretory function. Gastroenterology 1996;110:947-9.
33. El-Omar E, Penman I, Spence E, et al. The GRP test: A new clinical test of acid secretion-reproducibility data. Eur J Gastroenterol Hepatol 1994;6:417-21.
34. Peterson WL, Barnett CC, Evans DJ, et al. Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: The role of Helicobacter pylori. Am J Gastroenterol 1993;88:2038-43.
35. Levi S, Haddad G, Ghosh P, et al. Campylobacter pylori and duodenal ulcers: The gastrin link. Lancet 1989;1:1167-8.
36. Walsh JH, Maxwell V, Ferrari J, et al. Bombesin stimulates human gastric function by gastrin-dependent and independent mechanisms. Peptides 1981;2(suppl 2):193-8.
37. Lundell L, Lindstedt G, Olbe L. Origin of gastrin liberated by gastrin releasing peptide in man. Gut 1987;28:1128-33.
38. Hirschowitz BI, Tim LO, Helman CA, et al. Bombesin and G-17 dose responses in duodenal ulcer and controls. Dig Dis Sci 1985;30:1092-103.
39. Greenberg GR, Chan B, MacDonald TJ, et al. The role of vagal integrity in gastrin-releasing peptide-stimulated gastroenteropancreatic hormone release and gastric acid secretion. Regul Pept 195;10:179-87.
40. Solomon TE, Adrian TE. Intestinal inhibitors of acid secretion: Comparative potencies and effects on inhibitory hormones. Gastroenterology 1993;104:A196 (abstract).
41. Olbe L, Hamlet A, Dalenback, et al. A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer. Gastroenterology 1996;110:1386-94.
42. Moss SO, Legon S, Bishop A, et al. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992;340:930-2.
43. Sumii M, Sumii K, Tari A, et al. Expression of antral gastrin and somatostatin mRNA in Helicobacter pylori-infected subjects. Am J Gastroenterol 1994;89:1515-9.
44. Labenz J, Tillenburg B, Peitz U, et al. Long-term consequences of Helicobacter pylori eradication: Clinical aspects. Scand J Gastroenterol 1996;31(suppl 215):111-5.
45. Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996;110:725-32.
46. Miller LS, Vinayek R, Frucht H, et al. Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology 1990;98:341-6.
47. Collen MJ, Johnson DA, Sheridan MJ. Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease: Correlation with ranitidine therapy. Dig Dis Sci 1994;39:410-7.
48. Mittal RK, Holloway RH, Penagini R, et al. Transient lower esophageal sphincter relaxation. Gastroenterology 1995;109:601-10.
49. Miteal RK, McCallum RW. Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis. Gastroenterology 1988;95:593-9.
50. Blaser MJ. Helicobacter pylori phenotypes associated with peptic ulceration. Scand J Gastroenterol 1994;29(suppl 205):1-5.
51. Cover TL, Dooley CP, Blaser MJ. Characterization and human serologic response to proteins in Helicobacler pylori from broth culture and supernatants with vacuolating cytotoxin activity. Infect Immun 1990;58:603-10.
52. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein peptic ulceration and gastric pathology. Lancet 1991;338:332-5.
53. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128 kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90:5791-5.
54. Telford JL, Ghiara P, Dell'orco M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994;179:1653-8.
55. Cover TL, Cao P, Lind CD, et al. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993;61:5008-12.
56. Cover TL, Tummuru MKR, Cao P, et al. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994;269:10566-73.
57. Xiang Z, Censini S, Bayeli PF, et al. Analysis of expression of Cag A and Vac A virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that Cag A is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-8.
58. Shay SS, Eggli D, McDonald C, et al. Gastric emptying of solid food in patients with gastroesophageal reflux. Gastroenterology 1987;92: 459-65.
59. Keshavarzian A, Bushnell DL, Sontag S, et al. Gastric emptying in patients with severe reflux esophagitis. Am J Gastroenterol 1991;86: 738-42.
60. Schwizer W, Hinder RA, DeMeester TR. Does delayed gastric emptying contribute to gastroesophageal reflux disease? Am J Surg 1989; 157:74-9.
61. Minocha A, Mokshagundam S, Gallo SH, et al. Alterations in upper gastrointestinal motility in Helicobacter pylori-positive nonulcer dyspepsia. Am J Gastroenterol 1994;89:1797-800.
62. Barnett J, Behler EM, Appelman HD, et al. Campylobacter pylori is not associated with gastroparesis. Dig Dis Sci 1989;34:1677-80.
63. Scott AM, Kellow JE, Shuter B, et al. Intragastric distribution and gastric emptying of solids and liquids in functional dyspepsia: Lack of influence of symptom subgroups and H. pylori-associated gastritis. Dig Dis Sci 1993;38:2247-54.